Skip to main content

Table 1 Study indicators

From: The effect of ethnicity on outcomes in a practice-based trial to improve cardiovascular disease prevention

CONDITION

MEASURES

Hypertension1

Process measures:

 

• BP measurement in prior 12 months

 

• Diagnosis of hypertension for 3 measurements >= 140/90 in prior 12 months

 

• BP measurement in prior 3 months for patients with diagnosis of hypertension

 

Outcome measures:

 

• Most recent BP measurement < 140/90 for all patients

 

• Most recent BP measurements < 140/90 for patients with diagnosis of hypertension

Hyperlipidemia (General Population screening)2

Process measures:

 

• Measure of total cholesterol in prior 36 months

 

• Measure of HDL-C in prior 36 months

Coronary Heart Disease 1,2,3

Process measures:

 

• Measurement of LDL-cholesterol in prior 12 months

 

• Recorded diagnosis of hyperlipidemia for LDL-cholesterol > 130 mg/dl

 

• Medication for hyperlipidemia for LDL-cholesterol > 130 mg/dl

 

• Prescription of beta-blocker in patients with history of myocardial infarction

 

Outcome measures:

 

• Most recent LDL-cholesterol < 100 mg/dl

 

• Most recent BP measurement < 140/90

Heart Failure4

Process measure:

 

• Prescription of angiotensin converting enzyme inhibitor or angiotensin receptor blocker

Atrial Fibrillation5

Process measure:

 

• Prescription of oral anticoagulant

Diabetes Mellitus6

Process measures:

 

• Measurement of glycosylated hemoglobin in prior 12 months

 

• Measurement of LDL-cholesterol in prior 24 months

 

• BP measurement in prior 3 months

 

Outcome measures:

 

• Most recent glycosylated hemoglobin < 7 %

 

• Most recent LDL-cholesterol < 100 mg/dl

 

• Most recent BP measurement < 130/85

  1. 1 Adapted from The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). National Institute of Health, National Blood Pressure Education Program, NIH publication 98-4080, November 1997.
  2. 2 Adapted from Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269(23): 301523.
  3. 3 Adapted from American Heart Association Scientific Statement: Smith SC, Blair SN, Criqui MH, etal: Preventing Heart Attack and Death in Patients with Coronary Disease. Circulation. 1995;92:2–4. Although the AHA recommendation is to measure total cholesterol at least every 60 months, we were forced to restrict our measure to 36 months due to restrictions of the historical data.
  4. 4 Adapted from American Heart Association Scientific Statement: Williams JF, Bristow MR, Fowler MB, etal: Guidelines for the Evaluation and Management of Heart Failure. Circulation. 1995;92:2764–2784
  5. 5 Adapted from American Heart Association Scientific Statement: Prystowsky EN, Benson DW, Fuster, V, etal: Management of Patients with Atrial Fibrillation. Circulation 1996;93:1262–1277.
  6. 6 Adapted from American Diabetes Association, Diabetes Quality Improvement Project, Initial Measure Set (Final Version) August 14, 1998
Back to article page

International Journal for Equity in Health

ISSN: 1475-9276

Contact us